ITLN1 and hepatocellular carcinoma: Based on the observation in CCK-8 assay, colony formation assay, EdU assay, and cell cycle distribution, we concluded that PD98059 effectively counteracted the suppressing impact of ITLN1 on HCC cell proliferation and cell cycle progression (Fig. 4E and F and S5A and B).